Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles

Correction: Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles

Correction for 'Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles' by Mohammed Salah Ayoup et al. , RSC Adv. , 2024, 14 , 16713-16726, https://doi.org/10.1039/D4RA02222J .

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:RSC advances 2024-05, Vol.14 (25), p.17945-17945
Hauptverfasser: Ayoup, Mohammed Salah, Shawki, Islam, Abdel-Hamid, Hamida, Ghareeb, Doaa A, Masoud, Aliaa, Harras, Marwa F, El-Atawy, Mohamed, Alharbi, Nuha Salamah, Ismail, Magda M. F
Format: Artikel
Sprache:eng
Schlagworte:
Chemistry
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Correction for 'Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles' by Mohammed Salah Ayoup et al. , RSC Adv. , 2024, 14 , 16713-16726, https://doi.org/10.1039/D4RA02222J .
ISSN:2046-2069
2046-2069
DOI:10.1039/d4ra90066a